StonvexLoading…
StonvexStonvexStonvexCore line items from PRME's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $4.63M | $2.98M | $0.00 | $0.00 |
Operating Income | $-208.35M | $-202.47M | $-204.79M | $-116.54M |
Net Income | $-201.14M | $-195.88M | $-198.13M | $-121.82M |
EPS (Diluted) | $-1.35 | $-1.65 | $-2.18 | $-4.19 |
Total Assets | $342.73M | $297.51M | $193.85M | $360.31M |
Total Liabilities | $221.87M | $144.36M | $60.78M | $44.04M |
Cash & Equivalents | $63.03M | $182.48M | $41.57M | $187.62M |
Free Cash Flow OCF − CapEx | $-167.09M | $-130.16M | $-174.14M | $-147.92M |
Shares Outstanding | 180.51M | 131.16M | 97.38M | 97.21M |